Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 10 Nov 2003 |
| Novozymes, financial statement for 3. Quarter of 2003 | 5 Nov 2003 |
| Novozymes, quarterly statement of shareholdings | 25 Sept 2003 |
| Novozymes, DSM and Novozymes to continue alliance in feed enzymes | 23 Sept 2003 |
| Novozymes, Trading by insiders in Novozymes A/S B shares - statement (no. 10, 2003) | 9 Sept 2003 |